IGF-1 LR3 (1 mg Vial)
Complete dosage protocol and reconstitution guide for IGF-1 LR3 (1 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.
CAT No:
CAS No:
Synonyms/Alias:IGF-1 LR3
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Complete dosage protocol and reconstitution guide for IGF-1 LR3 (1 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.
Quickstart
Reconstitute: Add 3.0 mL bacteriostatic water → ~0.333 mg/mL concentration (333 mcg/mL).
Typical daily range: 20–50 mcg once daily subcutaneously (gradual titration recommended).
Easy measuring: At 0.333 mg/mL, 1 unit = 0.01 mL ≈ 3.33 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F) for up to 12 months; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days; avoid repeated freeze–thaw cycles.
Notes
Practical considerations for consistency, safety, and optimal outcomes. Sterile technique: Always use new, sterile insulin syringes for each injection; dispose immediately in a sharps container [5] . Follow “one needle, one syringe, only one time” practice. Site rotation: Systematically rotate injection sites between abdomen (at least 2 inches from navel), outer thighs, and upper arms to reduce local irritation and prevent tissue hardening [8] . Injection technique: Inject slowly and steadily; wait a few seconds before withdrawing the needle to prevent solution leakage. Hypoglycemia awareness:
Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.
Peptide Vials (IGF-1 LR3, 1 mg each): 8 weeks ≈ 3 vials (~2.24 mg total needed)
12 weeks ≈ 4 vials (~3.64 mg total needed)
16 weeks ≈ 6 vials (~5.04 mg total needed)
Insulin Syringes (U-100, 0.5 mL or 1 mL): Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes
Sharps Container: For safe disposal of used needles and syringes [5] .
Fast-acting carbohydrate source: Glucose tablets or juice on hand during cycle to address potential hypoglycemia symptoms, especially during dose titration [6] .
Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.
Email: kongq687@gmail.com
Address: Huangpu District, Guangzhou, China